About Me

Research Laboratory

George Kulik Lab - Designing more effective therapies for advanced prostate and other therapy-resistant cancers.

Educational Program Involvement

Cancer Biology PhD
Program Research Interest: Cellular defense and metabolism, Aberrant signaling pathways in tumor cells, Cell growth and survival, Molecular cancer epidemiology, Gene-environment interactions, Cancer control

Molecular Medicine and Translational Science PhD
Program Research Interest: Analytical approaches to molecular and cellular synthesis, structure and function, Genetics and gene regulation, Cell communications, Organ systems, Pathophysiology

Research

Publications

Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.. Sastry KS, Chouchane AI, Wang E, Kulik G, Marincola FM, Chouchane L. Cell Death Dis. 2017 06; 8(6):e2844.
Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation.. Zhang Q, Wan M, Shi J, Horita DA, Miller LD, Kute TE, Kridel SJ, Kulik G, Sui G. J Mol Cell Biol. 2016 Jun; 8(3):232-43.
Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network.. Kulik G. Asian J. Androl. ; 17(3):471-4.
Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells.. Sastry KS, Al-Muftah MA, Li P, Al-Kowari MK, Wang E, Ismail Chouchane A, Kizhakayil D, Kulik G, Marincola FM, Haoudi A, Chouchane L. Cell Death Differ. 2014 Dec; 21(12):1936-49.
Systems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapy.. Sun X, Bao J, Nelson KC, Li KC, Kulik G, Zhou X. PLoS Comput. Biol. 2013; 9(12):e1003358.

View More Publications

More Resources

More Resources

Institutes and Centers

Shared Resources and Cores

Public Health Sciences

Research and Faculty Labs

Clinical Trials

Symposia Series

George Kulik, DVM, PhD

George Kulik, DVM, PhD

About Me

Research Laboratory

Educational Program Involvement